Repurposing old drugs in oncology: Opportunities with clinical and regulatory challenges ahead
Author:
Affiliation:
1. Pharmaceutical Consultant; Gerrards Cross Buckinghamshire UK
2. Department of Pharmaceutical Medicine; School of Cancer and Pharmaceutical Sciences; Faculty of Life Sciences and Medicine; King's College; London UK
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/jcpt.12759/fullpdf
Reference232 articles.
1. Inventing new therapies without reinventing the wheel: the power of drug repurposing;Papapetropoulos;Br J Pharmacol,2018
2. The price we pay for progress: a meta-analysis of harms of newly approved anticancer drugs;Niraula;J Clin Oncol,2012
3. Cardiovascular safety of tyrosine kinase inhibitors: with a special focus on cardiac repolarisation (QT interval);Shah;Drug Saf,2013
4. Hepatotoxicity of tyrosine kinase inhibitors: clinical and regulatory perspectives;Shah;Drug Saf,2013
5. Tyrosine kinase inhibitor-induced interstitial lung disease: clinical features, diagnostic challenges, and therapeutic dilemmas;Shah;Drug Saf,2016
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Loratidine is associated with improved prognosis and exerts antineoplastic effects via apoptotic and pyroptotic crosstalk in lung cancer;Journal of Experimental & Clinical Cancer Research;2024-01-02
2. EZH2 as a potential therapeutic target for gastrointestinal cancers;Pathology - Research and Practice;2024-01
3. Redirection to the Drug Discovery: Antidiabetic Drugs Repurposing in Cancer;Drug Repurposing;2024
4. Unlocking the synthetic approaches and clinical application of approved small-molecule drugs for gastrointestinal cancer treatment: A comprehensive exploration;European Journal of Medicinal Chemistry;2023-12
5. Repurposing Drugs in Controlling Recurrent Platinum-Resistant Clear-Cell Ovarian Cancer;Case Reports in Oncological Medicine;2023-06-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3